Neuroendocrine Mechanisms of Developmental Massage Therapy (DMT) in Preterm Infants: Clinical Study
DMT
1 other identifier
interventional
46
1 country
3
Brief Summary
The purpose of this study is to see if daily massage therapy will help premature infants respond to stress better, as well as improve their growth and neurobehavioral development.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2008
Typical duration for not_applicable
3 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
July 24, 2008
CompletedFirst Posted
Study publicly available on registry
July 28, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 1, 2011
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2011
CompletedFebruary 8, 2013
February 1, 2013
3 years
July 24, 2008
February 6, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Growth
Weekly
Secondary Outcomes (2)
Salivary cortisol levels
Daily for first week; Weekly thereafter
Neurobehavioral Assessment
Weekly, Term, 3 months, 6 months
Study Arms (2)
DMT group
ACTIVE COMPARATORThese infants will receive tactile stimulation and developmental massage by a licensed therapist. This intervention will be done behind a screen in order to blind the therapy to NICU staff and parents.
SHAM control
PLACEBO COMPARATORThese infants will have no tactile stimulation or developmental massage done. The therapist will stand behind a screen but will not touch the infant. The screen will blind the NICU staff and parents to the study arm.
Interventions
Tactile stimulation and massage will be done by a licensed therapist
Eligibility Criteria
You may qualify if:
- Premature infants born between 29 4/7 and 32 3/7 weeks gestation by physical exam at birth, and with birth weight, length and head circumference between the 5th and 95th percentiles for gestational age.
You may not qualify if:
- Intrauterine growth less than the 5th or greater than the 95th percentiles for gestational age, congenital anomalies, complex cardiac defects, severe CNS injury, hypothyroidism, inborn errors of metabolism, or inability to establish full enteral feeds by day of life 14.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Utahlead
- National Institutes of Health (NIH)collaborator
Study Sites (3)
Intermountain Medical Center
Murray, Utah, 84107, United States
St. Mark's Hospital
Salt Lake City, Utah, 84124, United States
University of Utah
Salt Lake City, Utah, 84132, United States
Related Publications (1)
Moyer-Mileur LJ, Haley S, Slater H, Beachy J, Smith SL. Massage improves growth quality by decreasing body fat deposition in male preterm infants. J Pediatr. 2013 Mar;162(3):490-5. doi: 10.1016/j.jpeds.2012.08.033. Epub 2012 Oct 11.
PMID: 23062248DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Laurie J Moyer-Mileur, PhD
University of Utah
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, CARE PROVIDER
- Purpose
- BASIC SCIENCE
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
July 24, 2008
First Posted
July 28, 2008
Study Start
July 1, 2008
Primary Completion
July 1, 2011
Study Completion
July 1, 2011
Last Updated
February 8, 2013
Record last verified: 2013-02